Sharps Technology, Inc.

NasdaqCM STSS

Sharps Technology, Inc. Price to Earnings Ratio (P/E) on January 14, 2025

Sharps Technology, Inc. Price to Earnings Ratio (P/E) is NA on January 14, 2025, a NA change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Sharps Technology, Inc. 52-week high Price to Earnings Ratio (P/E) is NA on January 14, 2025, which is NA below the current Price to Earnings Ratio (P/E).
Sharps Technology, Inc. 52-week low Price to Earnings Ratio (P/E) is NA on January 14, 2025, which is NA below the current Price to Earnings Ratio (P/E).
Sharps Technology, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is NA.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqCM: STSS

Sharps Technology, Inc.

CEO	Mr. Robert M. Hayes
IPO Date	April 14, 2022
Location	United States
Headquarters	105 Maxess Road
Employees	57
Sector	Health Care
Industries Pharmaceuticals Biotechnology Medical Instruments

Description

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Key trends

Past 5 years